Citation sources

Updated weekly. Details via Crossref
Crossref Scopus Google Scholar
23 23 Search
2020
Comparison of tofogliflozin versus glimepiride as the third oral agent added to metformin plus a dipeptidyl peptidase‐4 inhibitor in Japanese patients with type 2 diabetes: A randomized, 24‐week, open‐label, controlled trial ( STOP‐OB )
Diabetes, Obesity and Metabolism
2019
Is metformin still the most efficacious first‐line oral hypoglycaemic drug in treating type 2 diabetes? A network meta‐analysis of randomized controlled trials
Obesity Reviews
2019
An Uncertain Safety
2019
Teneligliptin versus sitagliptin in Korean patients with type 2 diabetes inadequately controlled with metformin and glimepiride: A randomized, double-blind, non-inferiority trial
Diabetes, Obesity and Metabolism
2019
Intensification with dipeptidyl peptidase-4 inhibitor, insulin, or thiazolidinediones and risks of all-cause mortality, cardiovascular diseases, and severe hypoglycemia in patients on metformin-sulfonylurea dual therapy: A retrospective cohort study
PLOS Medicine
2019
Conducting and interpreting results of network meta-analyses in type 2 diabetes mellitus: A review of network meta-analyses that include sodium glucose co-transporter 2 inhibitors
Diabetes Research and Clinical Practice
2019
Validated Liquid Chromatographic Method for the Determination of (Canagliflozin, Dapagliflozin or Empagliflozin) and Metformin in the Presence of (1-Cyanoguanidine)
Journal of Chromatographic Science
2019
Multiple Antihyperglycemic Drug Use is Associated with Undernutrition Among Older Adults with Type 2 Diabetes Mellitus: A Cross-Sectional Study
Diabetes Therapy
2018
Management of Hyperglycemia in Type 2 Diabetes, 2018. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
Diabetes Care
2018
Combination Therapy of Oral Hypoglycemic Agents in Patients with Type 2 Diabetes Mellitus
The Journal of Korean Diabetes
2018
Rationale and Design of the STOP-OB Study for Evaluating the Effects of Tofogliflozin and Glimepiride on Fat Deposition in Type 2 Diabetes Patients Treated with Metformin/DPP-4 Inhibitor Dual Therapy
Diabetes Therapy
2018
Comparison of glucose-lowering agents after dual therapy failure in type 2 diabetes: A systematic review and network meta-analysis of randomized controlled trials
Diabetes, Obesity and Metabolism
2018
Consensus recommendations on sulfonylurea and sulfonylurea combinations in the management of Type 2 diabetes mellitus – International Task Force
Indian Journal of Endocrinology and Metabolism
2018
Management of hyperglycaemia in type 2 diabetes, 2018. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
Diabetologia
2018
Pharmacologic Glycemic Management of Type 2 Diabetes in Adults
Canadian Journal of Diabetes
2017
Pharmacotherapy of ‘treatment resistant’ type 2 diabetes
Expert Opinion on Pharmacotherapy
2017
Combination therapy of oral hypoglycemic agents in patients with type 2 diabetes mellitus
The Korean Journal of Internal Medicine
2017
Cognitive impairment in diabetes and poor glucose utilization in the intracellular neural milieu
Medical Hypotheses
2017
Combination Therapy of Oral Hypoglycemic Agents in Patients with Type 2 Diabetes Mellitus
Diabetes & Metabolism Journal
2017
Comparative Effectiveness of Adding Alogliptin to Metformin Plus Sulfonylurea with Other DPP-4 Inhibitors in Type 2 Diabetes: A Systematic Review and Network Meta-Analysis
Diabetes Therapy
2017
Efficacy and safety of metformin and sitagliptin based triple antihyperglycemic therapy (STRATEGY): a multicenter, randomized, controlled, non-inferiority clinical trial
Science China Life Sciences
2016
Management of diabetes in Morocco: results of the International Diabetes Management Practices Study (IDMPS) – wave 5
Therapeutic Advances in Endocrinology and Metabolism
2016
NUEVOS FÁRMACOS EN DIABETES MELLITUS
Revista Médica Clínica Las Condes